Analyzing...
Loading company...
Nothing flagged for monitoring
“Operates in Healthcare — Equipment & Devices.”
₹110 Cr revenue.
COGS 62.0%, employees 14.0%.
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 5.3%▼ | 12.3% |
| ROCE | 7.0%▼ | 15.3% |
| Net Margin | 7.0%▼ | 8.5% |
| EBITDA Margin | 10.7%▼ | 14.9% |
| Debt To Equity | 0.02x▼ | 0.10x |
| Rev Growth 3yr | -22.6%▼ | 15.2% |
| EPS Growth 3yr | -73.4%▼ | -17.4% |
Historical valuation data not available.
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | ₹143 Cr +30.7% | ₹110 Cr +19.3% | ₹92 Cr -17.4% | ₹111 Cr -56.4% | ₹256 Cr +19.7% | ₹213 Cr |
| Other Income | ₹9 Cr -27.0% | ₹12 Cr +18.3% | ₹11 Cr +48.0% | ₹7 Cr -7.7% | ₹8 Cr +173.2% | ₹3 Cr |
| Total Income | ₹152 Cr +24.8% | ₹122 Cr +19.2% | ₹102 Cr -13.5% | ₹118 Cr -55.0% | ₹263 Cr +21.7% | ₹216 Cr |
| COGS | ₹90 Cr +32.6% | ₹68 Cr +12.2% | ₹61 Cr -19.7% | ₹76 Cr -43.0% | ₹133 Cr +33.3% | ₹99 Cr |
| ₹140 Cr +15.8% | ₹121 Cr +15.0% | ₹105 Cr -18.7% | ₹129 Cr -36.1% | ₹202 Cr +31.4% | ₹154 Cr | |
| Profit Before Tax | ₹13 Cr +833.8% | ₹1 Cr ↑ Recovery | (₹3 Cr) +76.3% | (₹11 Cr) ↓ Decline | ₹61 Cr -2.2% | ₹62 Cr |
| ₹2 Cr +282.5% | ₹0.50 Cr ↑ Recovery | (₹0.75 Cr) +69.9% | (₹2 Cr) ↓ Decline | ₹16 Cr +0.4% | ₹16 Cr | |
| Net Profit | ₹11 Cr | ₹0.85 Cr ↑ Recovery | (₹2 Cr) +78.3% | (₹8 Cr) ↓ Decline | ₹45 Cr -3.0% | ₹46 Cr |
| Profit (Owners) | ₹11 Cr | ₹0.85 Cr ↑ Recovery | (₹2 Cr) +78.3% | (₹8 Cr) ↓ Decline | ₹45 Cr -3.0% | ₹46 Cr |
| Other Comprehensive Income | ₹0.31 Cr -6.7% | ₹0.33 Cr | ₹0.02 Cr ↑ Recovery | (₹0.07 Cr) ↓ Decline | ₹0.14 Cr | ₹0.01 Cr |
| EPS | ₹10.64 | ₹0.85 | (₹1.79) | (₹8.25) | ₹44.96 | ₹46.37 |
| Diluted Shares | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| Profit Loss From Discontinued Operations After Tax | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
No earnings call transcripts available.
Nureca Limited has informed the Exchange regarding 'Intimation regarding no change in the aggregate shareholding of the Promoter and Promoter Group of the Company pursuant to Inter Se Transfer of Shar...
Nureca Limited has informed the Exchange regarding 'Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015( PIT Regulations )'.
Nureca Limited has informed the Exchange regarding 'Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015( PIT Regulations )'.
Nureca Limited has informed the Exchange regarding Re-Appointment of MGSG AND ASSOCIATES as Internal Auditor of the company w.e.f. April 01, 2026.
Nureca Limited has informed the Exchange about Copy of Newspaper Publication
Nureca Limited has informed the Exchange about General Updates
Nureca Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Saurabh H Goyal has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regula...
Nureca Limited has informed the Exchange about Copy of Newspaper Publication
Nureca Limited has informed the Exchange about Copy of Newspaper Publication
Nureca Limited has informed the Exchange about General Updates
Nureca Limited has informed the Exchange about General Updates
Nureca Limited has informed the Exchange regarding a press release dated January 17, 2026, titled " Strong Q3 Performance :Sequential growth of 50% YoY growth for Q3 FY26, and 43% 9M YoY growth in FY2...
Nureca Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
Nureca Limited has informed the Exchange regarding Board meeting held on January 17, 2026.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.